Strategic Growth Palladium Equity Partners focuses on control-oriented investments in growth-focused industries (consumer, healthcare, industrials, services) with capital for add-ons, buyouts, and restructurings. This signals ongoing appetite for platform investments and bolt-on opportunities, suggesting SDRs should target portfolio companies seeking expansion capital or strategic acquisitions.

Healthcare and Durable Medical Equipment Recent activity includes acquiring DME Express and ongoing involvement in healthcare services, indicating continued interest in healthcare supply chain, durable medical equipment, and hospice-related providers. Sales outreach can map to mid-market firms in this space seeking growth equity, recapitalizations, or exits.

Portfolio Expansion Palladium has a history of adding on acquisitions and partnering with founders and management teams, with over 220 investments and a strategy that includes add-on acquisitions and growth capital. This highlights opportunities to present add-on acquisition financing or transition strategies to companies contemplating consolidation or exit pathways.

Recent Wins and Access Notable recent moves include acquisitions and asset sales involving notable firms, signaling active deal sourcing and a willingness to pursue complex transactions. Sales teams can leverage this momentum to approach target companies planning restructurings, divestitures, or strategic sales to private equity or strategic buyers.

Financial Footprint With over $3 billion AUM and revenue in the $50–100 million range, Palladium operates at a scale conducive to mid-market investments. Prospecting can focus on midsize companies in target sectors with EBITDA between $10 million and $75 million that may be receptive to control-oriented equity partnerships and leadership transitions.